Patients taking general blood pressure drugs should check the supply because of the risk of doubling their intended dosage and having harmful side effects.
The British regulators have announced warnings in the Lercanidipine hydrochloride refining pack due to the wrong printing of the label.
Pharmaceuticals and Medical Products Regulatory Organization (MHRA) said that some packs of 20 mg tablets were misrepresented as containing 10 mg purification and then distributed to patients taking lower doses.
Too much drug can cause problems such as fast or irregular heartbeats, dizziness and drowsiness.
MHRA said that patients should check if the drugs of the Recordati Pharmaceuticals Limited have the placement number MD4L07 as the expiration date of January 2028.
This code is printed on the foil of the blister pack.
According to MHRA, 7,700 packs were distributed.
Regulatory agencies generally say that patients with 10 mg versions of pills and patients affected by deployment should contact GP or pharmacists or NHS 111.
British regulatory agency
If this is impossible, you should take half of the 20mg tablet as a temporary action until you can talk to a medical professional.
Patients with 20mg doses should check if the drug is the right dose and then take it as normal, but if there is concern, contact the pharmacist.
Dr. Alison Cave, the chief safety officer of MHRA, said: ‘Patient safety is our top priority. We ask patients to check the packaging and follow our advice.
‘Medical professionals such as pharmacists should also return to suppliers instead of supplying drugs in the affected placement.’
Recordati Pharmaceuticals Limited is a recall of packages that are not yet distributed to patients.
Lercanidipine is a blood pressure drug and the heart is easier to pump blood around the body.
Tablets are 10 mg or 20 mg doses that patients take once a day, and patients usually start with lower doses.
More patients should contact NHS 111 than the recommended doses.
According to the NHS support data, last year, the UK shows that there are 4 million prescriptions of the Lercanidipine hydrochloride in the UK.
